Key Takeaways
- Restart Life Sciences has partnered with the University of Manitoba’s RCFTR to enhance its functional food product development.
- The collaboration focuses on scientific validation of ingredients, formulation efficacy, and product stability.
- Holy Crap Foods Inc. has been successfully integrated into the company’s health-focused portfolio, expanding its market reach.
Collaboration with RCFTR
Restart Life Sciences Corp. (CSE: HEAL), based in Vancouver, has announced a strategic collaboration with the Richardson Centre for Food Technology and Research (RCFTR) at the University of Manitoba. This partnership aims to support scientific research for food products, focusing on enhancing the efficacy and quality of Restart Life’s expanding portfolio in functional wellness.
The collaboration comes on the heels of Restart Life’s acquisition of Holy Crap Foods Inc., which is known for its clean-label functional food products. This acquisition enriches Restart Life’s offerings in digestive health and emphasizes the growing link between gut health and brain performance.
The RCFTR collaboration will involve rigorous scientific assessments to validate existing product formulations and optimize ingredient functionality. The aim is to improve bioavailability and ensure long-term stability for brands such as BrainQ™ and BrainBalls™. CEO Steve Loutskou emphasized the importance of grounding innovations in scientific research, which the RCFTR partnership facilitates through access to advanced expertise and facilities.
Dr. Michael Janzen, Research Development Manager at RCFTR, expressed enthusiasm about the project, noting that it aligns well with their research objectives. The partnership will focus on exploring ingredient quality, formulation integrity, and functional performance under various conditions.
Research initiatives will likely assess nutritional retention, ingredient behavior in formulations, and stability considerations. Preliminary evaluations may also look into bioavailability and the functional potential of active ingredients. The insights gained will guide product refinement and influence future research directions across the company’s health-focused brands.
In addition to these advancements, Restart Life has communicated updates regarding a previously announced loan financing agreement of CAD$250,000. The company clarified the terms, which include a 12% annual interest rate and the issuance of 2.5 million share purchase warrants.
About Restart Life Sciences Corp., it is a Canadian life sciences company striving to innovate within the functional food sector, focusing on products that support cognitive and digestive health. The company thanks its shareholders for their continuous support as it further develops its strategic initiatives.
For additional information about Restart Life Sciences, please refer to their website.
The content above is a summary. For more details, see the source article.